Stocks in Focus - Nu Skin Enterprises, Inc. (NYSE:NUS), The Dow Chemical Company (NYSE:DOW), Linear Technology Corporation (NASDAQ:LLTC)

Nu Skin Enterprises, Inc. (NYSE:NUS) said it entered into a new $375 million syndicated credit facility this month which it drew on in full to pay off other outstanding debt and for other corporate purposes. The multi-level marketer said the new credit agreement with various banks provided for a $127.5 million term loan facility, a 6.6 billion yen term loan facility, and a $187.5 million revolving credit facility, each with a term of five years.The credit facility will give it flexibility to return value to shareholders, although with restrictions. Nu Skin Enterprises, Inc. (NYSE:NUS) later clarified its plans to say it expects to continue to pay out a quarterly dividend. The term loan facilities will amortize in quarterly installments in amounts resulting in an annual amortization of 5.0% during the first year, 7.5% during the second year, 10.0% during the third year, 12.5% during the fourth year and 15.0% during the fifth year, NuSkin said.The Environmental Protection Agency (EPA) gave its approval to The Dow Chemical Company (NYSE:DOW) for its new herbicide, Enlist Duo, which was developed to kill "super weeds", those that have become resistant to Monsanto's (MON) RoundUp. The herbicide contains 2,4-D along with glyphosate. Using both ingredients should enable farmers to kill weeds that have become resistant to RoundUp, which uses only glyphosate. Two,Four-D was one of the active ingredients in Agent Orange, the defoliant that was used during the Vietnam War. though has not been linked to cancer, birth defects or diabetes. Dow will begin selling Enlist Duo in the spring of 2015. Shares of The Dow Chemical Company (NYSE:DOW) are trading with a 52-week range of $38.16 to $54.97.Linear Technology Corporation (NASDAQ:LLTC), the analog chip-maker reported fiscal Q1 revenue came up just shy of Wall Street expectations and missed analyst estimates for revenue during the current quarter. Revenue during the three months ended Sept. 28 rose 9% year over year to $371.1 million, lagging the Capital IQ consensus by around $1.2 million. Net income during the quarter slipped to $129.5 million, or $0.53 per share, down narrowly from a $129.8 million profit during the same period last year and matching analyst estimates.Linear Technology Corporation (NASDAQ:LLTC) said Q3 net income was hurt by its effective income tax rate during the quarter rising to 26%, more than offsetting the benefit of reduced interest costs after LLTC retired all of its convertible senior notes at the end of the prior quarter. Looking forward, the company is projecting a 3% to 6% decline in revenue compared with Q1. That equates to a revenue range of $160.8 million to $166 million, trailing the Street view for Q2 by at least $2.59 million.